Adaptive Enterprise Architecture for the Digital Healthcare Industry: A Digital Platform for Drug Development
| Autor: | Murlikrishna Viswanathan, Matthew Bass, Osamu Nakamura, Alfred Zimmermann, Yoshimasa Masuda, Shuichiro Yamamoto |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Enterprise architecture framework
Knowledge management Computer science Process (engineering) Enterprise architecture Cloud computing 02 engineering and technology Structuring 020204 information systems 0202 electrical engineering electronic engineering information engineering Reference architecture digital healthcare lcsh:T58.5-58.64 lcsh:Information technology business.industry cloud computing Digital transformation knowledge management artificial intelligence Digital architecture digital platform enterprise architecture digital transformation 020201 artificial intelligence & image processing business Information Systems |
| Zdroj: | Information, Vol 12, Iss 67, p 67 (2021) Information Volume 12 Issue 2 |
| ISSN: | 2078-2489 |
| DOI: | 10.3390/info12020067 |
| Popis: | Enterprise architecture (EA) is useful for effectively structuring digital platforms with digital transformation in information societies. Moreover, digital platforms in the healthcare industry accelerate and increase the efficiency of drug discovery and development processes. However, there is the lack of knowledge concerning relationships between EA and digital platforms, in spite of the needs of it. In this paper, we investigated and analyzed the process of drug design and development within the healthcare industry, together with related work in using an enterprise architecture framework for the digital era named the Adaptive Integrated Digital Architecture Framework (AIDAF), specifically supporting the design of digital platforms there. Based on this analysis, we evaluate a method and propose a new reference architecture for promoting digital platforms in the healthcare industry, with future specific aspects of them making effective use of Artificial Intelligence (AI). The practical and theoretical contributions include: (1) Streamlined processes through digital platforms in organizations. (2) Informal knowledge supply and sharing among organizational members through digital platforms. (3) Efficiency and effectiveness in planning production and business for drug development. The findings indicate that EA with digital platforms using the AIDAF contribute to digital transformation with effectiveness for new drugs in the healthcare industry. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|